Our in vivo data substantiate that through this mechanism, Id1-expressing ESCC tumours can indirectly promote the functional incorporation of VEGFR1+ bone marrow cells into primary tumours and secondary sites to facilitate tumour growth and formation of pre-metastatic niche. The gene discussed is ID1; the disease is esophageal squamous cell carcinoma.